Progressive multifocal leukoencephalopathy following five lines of therapy and three autologous bone marrow transplants for multiple myeloma
- PMID: 32205382
- PMCID: PMC7103853
- DOI: 10.1136/bcr-2019-233552
Progressive multifocal leukoencephalopathy following five lines of therapy and three autologous bone marrow transplants for multiple myeloma
Abstract
A 59-year-old man, with a background of multiply relapsed myeloma, presented with a 3-week history of confusion, short-term memory impairment and behavioural changes. CT head showed bilateral white matter changes and numerous, large lytic lesions of the skull vault. MRI brain revealed multiple areas of hyperintensity on T2-weighted sequences which did not enhance (many of which showed diffusion restriction) unexpectedly bringing progressive multifocal leukoencephalopathy (PML) into the differential. Initial cerebrospinal fluid studies were largely unremarkable, aside from a mildly elevated protein; cultures were negative. PCR for the John Cunningham (JC) virus was positive. Considering the patient's medical history and rapidily progressive symptoms, a palliative approach was adopted, with the patient dying 14 days later. We present this case as an example of PML in a patient with multiple myeloma, highlighting the need to consider this diagnosis in an enlarging population of heavily treated, severely immunocompromised, patients.
Keywords: haematology (drugs and medicines); malignant disease and immunosuppression.
© BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Figures


Similar articles
-
Concurrent progressive multifocal leukoencephalopathy and central nervous system infiltration by multiple myeloma: A case report.J Oncol Pharm Pract. 2019 Jun;25(4):998-1002. doi: 10.1177/1078155218769367. Epub 2018 Apr 24. J Oncol Pharm Pract. 2019. PMID: 29690814
-
Prolonged Immunosuppression in Relapsed, Refractory Multiple Myeloma Leading to Cerebral Toxoplasmosis and Progressive Multifocal Leukoencephalopathy.Clin Lymphoma Myeloma Leuk. 2019 Dec;19(12):e625-e628. doi: 10.1016/j.clml.2019.09.617. Epub 2019 Oct 9. Clin Lymphoma Myeloma Leuk. 2019. PMID: 31676197 No abstract available.
-
Progressive multifocal leukoencephalopathy after autologous peripheral blood stem cell transplantation in a patient with multiple myeloma treated with combination therapy.J Neurol Sci. 2016 Sep 15;368:304-6. doi: 10.1016/j.jns.2016.07.045. Epub 2016 Jul 22. J Neurol Sci. 2016. PMID: 27538654 No abstract available.
-
Probable progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome with immunosuppressant dose reduction following lung transplantation: a case report and literature review.BMC Neurol. 2019 Oct 31;19(1):263. doi: 10.1186/s12883-019-1493-1. BMC Neurol. 2019. PMID: 31672142 Free PMC article. Review.
-
[A case of progressive multifocal leukoencephalopathy presenting white matter MRI lesions extending over the cerebral cortex and a marked decrease in cerebral blood flow on SPECT, and associated with HTLV-I infection].Rinsho Shinkeigaku. 2005 Jun;45(6):426-30. Rinsho Shinkeigaku. 2005. PMID: 16022467 Review. Japanese.
Cited by
-
Leukoencephalopathy During Daratumumab-Based Therapy: A Case Series of Two Patients with Multiple Myeloma.Onco Targets Ther. 2022 Sep 6;15:953-962. doi: 10.2147/OTT.S365657. eCollection 2022. Onco Targets Ther. 2022. PMID: 36097632 Free PMC article.
-
Progressive multifocal leukoencephalopathy in multiple myeloma. A literature review and lessons to learn.Ann Hematol. 2021 Jan;100(1):1-10. doi: 10.1007/s00277-020-04294-x. Epub 2020 Oct 3. Ann Hematol. 2021. PMID: 33009935 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical